Giuseppe Terracina

Statistics

Publications

Citations

809

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Giuseppe Terracina is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, enzyme inhibition, and drug discovery.

Publications per year

1998–2020

Publications

Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice

Nicholas B. Hastings, Xiaohai Wang, Lixin Song et al. · Molecular Neurodegeneration · 2017 · 154 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Biochemical Characterization of the γ-Secretase Activity That Produces β-Amyloid Peptides

Lili Zhang, Lixin Song, Giuseppe Terracina et al. · Biochemistry · 2001 · 88 citations

Life Sciences, Biochemistry, Neuroscience +16

MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy

Xiaohai Wang, Wenping Li, Jacob Marcus et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 75 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Purification and Preliminary Characterization of a Serine Hydrolase Involved in the Microbial Degradation of Polychlorinated Biphenyls

Stephen Y. K. Seah, Giuseppe Terracina, Jeffrey T. Bolin et al. · Journal of Biological Chemistry · 1998 · 70 citations · Full text

Life Sciences, Microbiology, Molecular Biology +14

Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation

Mihirbaran Mandal, Zhaoning Zhu, Jared N. Cumming et al. · Journal of Medicinal Chemistry · 2012 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 19